A preliminary single-centre, randomised, comparative study of the Eakin wound dressing in the management of superficial/partial thickness wounds

Not Applicable

Completed

• Conditions: Wounds; Skin and Connective Tissue Diseases

• Registration Number: ISRCTN60271166
• Lead Sponsor: TG Eakin Limited (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2005-06-15
• Last Update Posted: 3 April 2017

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

All patients presenting superficial/partial thickness wounds which could or would normally be treated with a 'hydrocolloid' wound dressing, and who are not precluded by the exclusion criteria below, will be invited to participate in this clinical trial.

Exclusion Criteria

Patients will be excluded from the trial under the following circumstances:
1. Wound is >5 cm length or breadth
2. Wound is >0.5 cm depth
3. Wound involving muscle, tendon or bone
4. Wound infection is suspected
5. Where informed consent is withheld
6. Where patients are unable to give informed consent due to legal incompetence, unless informed consent is available from a responsible relative or guardian
7. Where, in the physician's opinion, inclusion in the trial is not advised

Study & Design

• Study Type: Interventional
• Study Design: Not specified